Elanco Animal Health Incorporated's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 4.76, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the Elanco Animal Health Incorporated in Jun 30 2026 quarter, has decreased to 77 days, compared to 78 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 351 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2422, from overall ranking in the first quarter 2026 at 2651.

What is Receivable Turnover Ratio?
What is Elanco Animal Health Incorporated Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ELAN Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	4.44 %	8.87 %	6.09 %	7.85 %	2.13 %
Y / Y Revenue Change	10.23 %	14.92 %	12.16 %	10.39 %	4.81 %
Receivable Turnover Ratio (TTM)	4.76	4.69	4.62	4.56	4.54
ELAN's Total Ranking	# 2422	# 2651	# 2199	# 2089	# 1460
Accounts Receivable average collection period days	77	78	79	80	80
Seq. Receivable Change	-0.17 %	22.77 %	-3.59 %	-11.6 %	4.06 %
Seq. Revenue Change	-0.22 %	19.84 %	0.62 %	-8.38 %	4.02 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 100
Healthcare Sector	# 352
Overall Market	# 2422

Receivable Turnover Ratio Statistics
High	Average	Low
0.37	0.31	0.24
(Jun 30 2026)		(Dec 31 2020)

ELAN Company Profile • Back to ELAN Efficiency Comparisons • Compare ELAN Receivables Turnover Ratio to its Competitors

Financial Statements
Elanco Animal Health Incorporated's Accounts Receivable	$ 1,152 Millions	Visit ELAN's Balance sheet
Elanco Animal Health Incorporated's Sales TTM	$ 5,020 Millions	Visit ELAN's Income Statement
Sources of ELAN's Revenues		Visit ELAN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ELAN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ELAN's Growth Rates	ELAN's Roa	ELAN's Inventory Turnover Ratio	ELAN's Dividend Comparisons
ELAN's Profitability Ratios	ELAN's Roi	ELAN's Asset Turnover Ratio	ELAN's Dividend Growth
ELAN's Valuation Ratios	ELAN's Roe	ELAN's Financial Strength Ratios	ELAN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Milestone Scientific Inc	11.82	$ 8.855 Millions	$ 0.749 Millions
Marpai Inc	11.71	$ 16.635 Millions	$ 1.420 Millions
Catheter Precision Inc	11.62	$ 1.915 Millions	$ 0.165 Millions
Icu Medical Inc	11.42	$ 2,159.998 Millions	$ 189.166 Millions
National Healthcare Corp	11.40	$ 1,559.020 Millions	$ 136.723 Millions
Nrc Health	11.35	$ 139.996 Millions	$ 12.337 Millions
Picard Medical Inc	11.34	$ 5.983 Millions	$ 0.528 Millions
Veracyte Inc	11.07	$ 544.735 Millions	$ 49.194 Millions
International Stem Cell Corporation	10.91	$ 9.514 Millions	$ 0.872 Millions
Premier Air Charter Holdings Inc	10.66	$ 31.562 Millions	$ 2.961 Millions
C4 Therapeutics Inc	10.65	$ 35.039 Millions	$ 3.290 Millions
Kymera Therapeutics Inc	10.50	$ 105.000 Millions	$ 10.000 Millions
Lifeloc Technologies Inc	10.48	$ 9.269 Millions	$ 0.884 Millions
Irhythm Holdings Inc	10.32	$ 825.702 Millions	$ 80.007 Millions
Immucell Corporation	10.29	$ 29.777 Millions	$ 2.893 Millions
Addus Homecare Corp	10.23	$ 1,475.610 Millions	$ 144.195 Millions
Dariohealth Corp	10.23	$ 21.196 Millions	$ 2.072 Millions
Biodesix Inc	10.21	$ 102.939 Millions	$ 10.081 Millions
Radnet Inc	10.11	$ 2,268.932 Millions	$ 224.447 Millions
Utah Medical Products Inc	9.88	$ 35.679 Millions	$ 3.612 Millions
Lensar Inc	9.75	$ 60.264 Millions	$ 6.184 Millions
Biolife Solutions Inc	9.67	$ 102.718 Millions	$ 10.626 Millions
Encompass Health Corporation	9.57	$ 6,206.100 Millions	$ 648.325 Millions
The Oncology Institute Inc	9.57	$ 587.244 Millions	$ 61.364 Millions
Alumis inc	9.44	$ 7.398 Millions	$ 0.784 Millions
Enanta Pharmaceuticals Inc	9.29	$ 65.258 Millions	$ 7.027 Millions
Neuronetics Inc	9.24	$ 154.594 Millions	$ 16.732 Millions
Myomo Inc	9.24	$ 44.242 Millions	$ 4.790 Millions
Harmony Biosciences Holdings inc	9.22	$ 960.191 Millions	$ 104.164 Millions
Pavmed Inc	9.16	$ 0.126 Millions	$ 0.014 Millions

Date modified: 2026-09-08T13:46:10+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.